The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
Disorders of Bone Remodeling
Open accessAbstract
The skeleton provides mechanical support for stature and locomotion, protects vital organs, and controls mineral homeostasis. A healthy skeleton must be maintained by constant bone modeling to carry out these crucial functions throughout life. Bone remodeling involves the removal of old or damaged bone by osteoclasts (bone resorption) and the subsequent replacement of new bone formed by osteoblasts (bone formation). Normal bone remodeling requires a tight coupling of bone resorption to bone formation to guarantee no alteration in bone mass or quality after each remodeling cycle. However, this important physiological process can be derailed by a variety of factors, including menopause-associated hormonal changes, age-related factors, changes in physical activity, drugs, and secondary diseases, which lead to the development of various bone disorders in both women and men. We review the major diseases of bone remodeling, emphasizing our current understanding of the underlying pathophysiological mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“OPG, a soluble receptor also produced by osteoblasts that acts as a decoy receptor and neutralizes RANKL, prevents RANKL from interacting with RANK and consequently inhibits osteoclast proliferation, activity, and survival [73, 74].”
From The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms (2018) · cites this paper as [73]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Once RANKL binds to its natural receptor, expressed by osteoclast precursor cells, it stimulates osteoclast precursor differentiation to active mature osteoclasts and accelerates bone resorption [73].”
From The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms (2018) · cites this paper as [73]
In the citing paper
“Abnormal increase in osteoclast formation and activity leads to some bone diseases such as osteoporosis, where resorption exceeds formation causing decreased bone density and increased bone fractures [105].”
From Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells (2015) · cites this paper as [105]
In the citing paper
“In patients with chronic liver disease, the balance between osteoclasts and osteoblasts is affected by liver disease, resulting in BRU imbalance [46,50].”
From Bone diseases in patients with chronic liver disease (2019) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidants, oxidative stress and the biology of ageing
Finkel, T., & Holbrook, N. J. (2000) · Nature · doi:10.1038/35041687 · Cited by 9,413
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670
Osteoporosis Prevention, Diagnosis, and Therapy
NIH Consensus Development Panel on Osteoporosis Prevention, D. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.6.785 · Cited by 5,529
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Mitochondria, Oxidants, and Aging
Balaban, R. S., Nemoto, S., & Finkel, T. (2005) · Cell · doi:10.1016/j.cell.2005.02.001 · Cited by 4,388
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224
Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,639
Research works printed but not linked: 11
- McGowen JA, 2004, Bone Health and Osteoporosis: A Report of the Surgeon General, 69
- Raisz LG., 1988, Ciba Found. Symp., 136, 226
- Mundy GR., 1991, Ciba Found. Symp., 157, 137
- Andersen TL, 2009, Br. J. Haematol., 48, 551
- Heaney RP, 1978, J. Lab. Clin. Med., 92, 964
- 10.1210/en.142.6.2205 · DOI · Paper page
- 10.1172/JCI200317215 · DOI · Paper page
- 10.1210/jc.83.12.4257 · DOI
- Peretz A, 1989, J. Rheumatol., 16, 363
- Takata S, 2001, J. Med. Investig., 48, 147
- Block GA, 2006, Clinical Guide to the Basics of Bone and Mineral Metabolism in CKD, 77
Cited by
Sorted by citations
Items 101–200 of 1,000
OTUB1 promotes osteoblastic bone formation through stabilizing FGFR2
Zhu, Q. N., Fu, Y., Cui, C., Ding, Y., Deng, Z., Ning, C., Hu, F., Qiu, C., Yu, B., Zhou, X., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01354-2 · Cited by 81
“Disruption of this process is related to multiple diseases, such as osteoporosis and spontaneous fracture.(1) Cumulative evidences suggest that bone homeostasis is regulated by cytokines and growth factors, including fibroblast growth factors (FGFs).”
BackgroundMukherjee, A., & Rotwein, P. S. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.06361-11 · Cited by 84
“The mechanism appears to be decreased accumulation of RANKL and m-CSF, the critical secreted factors that stimulate osteoclast differentiation (11, 14, 15).”
BackgroundInfluentialRecent Advances in Osteoclast Biological Behavior
Sun, Y., Li, J., Xie, X., Gu, F., Sui, Z., Zhang, K., & Yu, T. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.788680 · Cited by 83
“Continuous remodeling is necessary to maintain these critical capabilities by minimizing bone damage accumulation and preserving both bone mechanical strength and calcium balance (Clarke, 2008; Feng and McDonald, 2011).”
BackgroundAguilar, A., Gifre, L., Ureña, P., Carrillo‐López, N., Rodríguez-García, M., Massó, E., Silva, I. D., López‐Báez, V., Sánchez-Baya, M., Prior-Español, Á., et al. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1177829 · Cited by 80
“This is known as woven bone, and this increase in osteoid is known as hyperosteoidosis, which occurs as a consequence of increased remodelling and not due to a delay in mineralization, as is the case with osteomalacia (Malluche et al., 1982; Feng and McDonald, 2011; Hruska et al., 2017).”
BackgroundChoi, S., Friedrichs, J., Song, Y. H., Werner, C., Estroff, L. A., & Fischbach, C. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.05.002 · Cited by 78
Bone Remodeling and the Role of TRAF3 in Osteoclastic Bone Resorption
Boyce, B. F., Li, J., Xing, L., & Yao, Z. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02263 · Cited by 84
“, rheumatoid arthritis) (32), endocrine disorders (20, 33), and metastatic cancers (34, 35) that spread to bone, these factors typically increase bone resorption and inhibit bone formation, leading to generalized bone loss (osteoporosis) or to localized, radiologically lytic lesions.”
BackgroundKawai, S., Yoshitomi, H., Sunaga, J., Alev, C., Nagata, S., Nishio, M., Hada, M., Koyama, Y., Uemura, M., Sekiguchi, K., et al. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0410-7 · Cited by 76
Kim, B., Lee, S. H., Koh, J., & Kim, G. S. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2363-0 · Cited by 79
“In more detail, substantial evidence indicates that estrogen deficiency during menopause can cause relative increases in osteoclastic bone resorption through directly affecting bone cells [33] and indirectly involving diverse mechanisms, such as reactive oxygen species, cytokines, and growth factors [34, 35], resultin…”
BackgroundSerum microRNAs as novel biomarkers for osteoporotic vertebral fractures
Zarecki, P., Hackl, M., Grillari, J., Debono, M., & Eastell, R. (2019) · Bone · doi:10.1016/j.bone.2019.115105 · Cited by 81
Osteoporosis in Chronic Obstructive Pulmonary Disease
Sarkar, M. S., Bhardwaj, R., Madabhavi, I., & Khatana, J. (2015) · Clinical Medicine Insights Circulatory Respiratory and Pulmonary Medicine · doi:10.4137/ccrpm.s22803 · Cited by 84
Epigenetic regulation of bone remodeling by natural compounds
Raut, N. A., Wicks, S. M., Lawal, T. O., & Mahady, G. B. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104350 · Cited by 73
Chi, J., Wang, M., Chen, J., Hu, L., Chen, Z., Backman, L. J., & Zhang, W. (2022) · Biomimetics · doi:10.3390/biomimetics7030131 · Cited by 77
“Normal bone remodeling requires a tight coupling of bone resorption to bone formation in order to guarantee no alteration in bone mass or quality after each remodeling cycle [166].”
BackgroundAn activator of the cAMP/PKA/CREB pathway promotes osteogenesis from human mesenchymal stem cells
Kim, J., Choi, J. S., Kim, Y. H., Jin, S. H., Lim, S., Jang, H., Kim, K., Ryu, S. H., & Suh, P. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24171 · Cited by 76
“PTH functions as a major mediator of bone remodeling by both decreasing osteoblasts apoptosis and increasing osteoblasts differentiation (Strewler et al., 1987; Jilka, 2007; Khosla et al., 2008).”
BackgroundInfluentialThe Role of Substance P in the Regulation of Bone and Cartilage Metabolic Activity
Li, F., Xu, F., Lin, X., Wu, F., Zhong, J.-Y., Wang, Y., Guo, B., Zheng, M.-H., Shan, S., & Yuan, L.-Q. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00077 · Cited by 62
“Bone Remodeling The balance between osteoclastic bone resorption and osteogenic bone formation processes in bone metabolism is the key to maintaining normal bone mass (21).”
BackgroundTang, L., Wu, M., Lu, S., Zhang, H., Shen, Y., Shen, C., Liang, H., Ge, H., Ding, X., & Wang, Z. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4230 · Cited by 76
“coordinated cellular activities between osteoblasts and osteoclasts.((1,2)) Osteoblasts are responsible for bone matrix deposition”
BackgroundBone marrow niches in the regulation of bone metastasis
Chen, F., Han, Y., & Kang, Y. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01329-6 · Cited by 77
Vijayan, V., Khandelwal, M., Manglani, K., Gupta, S., & Surolia, A. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12434 · Cited by 78
“Osteoporosis is a progressive and systemic bone disorder prevalent in the ageing population of both developed and developing countries (Feng and McDonald, 2011).”
BackgroundMederle, O. A., Balaş, M., Ioanoviciu, S. D., Gurban, C., Tudor, A., & Borza, C. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s170111 · Cited by 75
“tion of bone structure is caused by an imbalance in bone remodeling with increased osteoclasts’ activity and decreased osteoblasts’ activation.(1,2)”
BackgroundBio‐Inspired Mechanotactic Hybrids for Orchestrating Traction‐Mediated Epithelial Migration
Cai, P., Layani, M., Leow, W. R., Amini, S., Liu, Z., Qi, D., Hu, B., Wu, Y., Miserez, A., Magdassi, S., et al. (2016) · Advanced Materials · doi:10.1002/adma.201505300 · Cited by 74
Chemerin neutralization blocks hematopoietic stem cell osteoclastogenesis
Muruganandan, S., Dranse, H. J., Rourke, J. L., McMullen, N. M., & Sinal, C. J. (2013) · Stem Cells · doi:10.1002/stem.1450 · Cited by 73
Fan, X., Zhao, Z., Gu, Y., Han, J., Ye, K., & Zhang, Y. (2021) · eLife · doi:10.7554/elife.64872 · Cited by 74
Tuning the surface potential to reprogram immune microenvironment for bone regeneration
Li, M., Chu, X., Wang, D., Jian, L., Liu, L., Yao, M., Zhang, D., Zheng, Y., Liu, X., Zhang, Y., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121408 · Cited by 72
Huang, M., Huang, Y., Liu, H., Tang, Z., Chen, Y., Huang, Z., Xu, S., Du, J., & Jia, B. (2022) · Biomaterials Science · doi:10.1039/d2bm01036d · Cited by 72
Effects of Taxifolin on Osteoclastogenesis in vitro and in vivo
Cai, C., Liu, C., Zhao, L., Liu, H., Li, W., Guan, H., Zhao, L., & Xiao, J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01286 · Cited by 74
“The imbalance caused by excessive bone resorption will lead to various osteopathic diseases, such as osteoporosis and Paget’s disease (Feng and McDonald, 2011).”
BackgroundPark, P. S. U., Raynor, W., Sun, Y. Y., Werner, T. J., Rajapakse, C. S., & Alavi, A. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126504 · Cited by 72
“When bone resorption becomes excessive as a result of physiological aging or hormonal imbalances, metabolic bone disease, such as osteoporosis, can occur [4].”
BackgroundDuraipandy, N., Ye, Z., Wang, L., Ge, L., & Pathak, J. L. (2021) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10262 · Cited by 76
“Certain pathological conditions disrupt the osteoblast and osteoclast function, causing bone loss or excessive bone mass.(61) Osteocytes are embedded in the”
BackgroundClinical Potential of Mesenchymal Stem Cell-Derived Exosomes in Bone Regeneration
Torrecillas-Baena, B., Pulido-Escribano, V., Dorado, G., Gálvez-Moreno, M. Á., Camacho-Cardeñosa, M., & Casado‐Díaz, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134385 · Cited by 75
“The latter may be the result of bone fragility, due to loss of bone mass or trauma [6].”
BackgroundA novel approach to inhibit bone resorption: exosite inhibitors against cathepsin K
Panwar, P., Søe, K., Guido, R. V. C., Bueno, R. V., Delaissé, J., & Brömme, D. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13383 · Cited by 71
“Docking was performed using XP (Extra Precision mode) docking protocol (Friesner et al., 2006), and visual inspection was employed to select the representative conformation for the exosite inhibitor.”
MethodHeo, S., Ko, S., Nam, S. Y., Oh, J., Kim, Y., Kim, J., Kim, N., Yi, M., & Jung, W. (2018) · Cell Biochemistry and Function · doi:10.1002/cbf.3325 · Cited by 71
Langan, D., Perkins, D. J., Vogel, S. N., & Moudgil, K. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042017 · Cited by 71
“In health, for example, bone resorption may increase to keep pace with bone formation for proper bone sculpting [11].”
BackgroundKim, J., Kim, J. J., Kim, Y. H., Kim, K., Ryu, S. H., Lee, T. G., & Suh, P. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24123 · Cited by 71
“2012 Wiley Periodicals, Inc. Bone provides mechanical support, protects vital tissues, such as bone marrow and the brain, and acts as a metabolic organ, with major reserves of calcium and phosphate (Feng and McDonald, 2011).”
BackgroundShu, L., Zhang, H., Boyce, B. F., & Xing, L. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1938 · Cited by 76
TNF-α mediates the stimulation of sclerostin expression in an estrogen-deficient condition
Kim, B., Bae, S. J., Lee, S.-Y., Lee, Y., Baek, J., Park, S., Lee, S. H., Koh, J., & Kim, G. S. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.06.100 · Cited by 69
Liu, Y., Yang, S., Cao, L., Zhang, X., Wang, J., & Liu, C. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110622 · Cited by 70
Bioprinting and organ-on-chip applications towards personalized medicine for bone diseases
Arrigoni, C., Gilardi, M., Bersini, S., Candrian, C., & Moretti, M. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-017-9741-5 · Cited by 68
Crosstalk Between the Neuroendocrine System and Bone Homeostasis
Zhao, Y., Peng, X., Wang, Q., Zhang, Z., Wang, L., Xu, Y., Yang, H., Bai, J., & Geng, D. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad025 · Cited by 75
More than nervous: The emerging roles of plexins
Perälä, N., Sariola, H., & Immonen, T. (2012) · Differentiation · doi:10.1016/j.diff.2011.08.001 · Cited by 66
“Impaired bone homeostasis may lead to, for example, osteoporosis that is characterised by low bone density and fragility, or osteopetrosis characterised by increased bone density but similarly leading to brittle bones (Feng and McDonald, 2011).”
BackgroundThe Role of NRF2 in Bone Metabolism – Friend or Foe?
Han, J., Yang, K., An, J., Jiang, N., Fu, S., & Tang, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.813057 · Cited by 67
“Bone formation and resorption are closely coupled and regulated by various hormones, nervous system and mechanical factors during this process (1, 7, 9).”
BackgroundPharmacological Properties of Ginsenoside Re
Gao, X., Liu, G., Zhang, J.-X., Wang, L., Xu, C., Yan, Z.-A., Wang, A., Su, Y.-F., Lee, J.-J., Piao, G., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.754191 · Cited by 67
Bone Microvasculature: Stimulus for Tissue Function and Regeneration
Lee, E. J., Jain, M., & Alimperti, S. (2020) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2020.0154 · Cited by 66
Postmenopausal Osteoporosis: A Literature Review
Bhatnagar, A., & Kekatpure, A. L. (2022) · Cureus · doi:10.7759/cureus.29367 · Cited by 79
“Some investigations have found that IL-1 and TNF augment the formation of osteoclast cells by directly promoting the activity of osteoclast precursors [41-44].”
BackgroundInfluentialMathavan, N., Turunen, M. J., Tägil, M., & Isaksson, H. (2015) · Calcified Tissue International · doi:10.1007/s00223-015-9991-7 · Cited by 66
Novel insights into the coupling of osteoclasts and resorption to bone formation
Durdan, M., Azaria, R. D., & Weivoda, M. M. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.10.008 · Cited by 69
Immunomodulation Effect of Biomaterials on Bone Formation
Zhao, T., Chu, Z., Ma, J., & Ouyang, L. (2022) · Journal of Functional Biomaterials · doi:10.3390/jfb13030103 · Cited by 69
“Bone modeling is one of the most important events in the skeletal system because it is responsible for altering and adjusting bone structure to meet changing mechanical needs, as well as assisting with the repair of microdamage in the bone matrix to ensure timely bone metabolism and to prevent severe pathological prob…”
BackgroundThe biological effects of tocotrienol on bone: a review on evidence from rodent models
Chin, K., & Ima-Nirwana, S. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s79660 · Cited by 65
“An imbalance in bone remodeling, whereby the rate of bone resorption is faster than bone formation, will result in osteoporosis.(2) Osteoporosis is a metabolic bone disease suffered by both men and women.”
BackgroundAubin, G. G., Baud’huin, M., Lavigne, J., Brion, R., Gouin, F., Lepelletier, D., Jacqueline, C., Heymann, D., Asehnoune, K., & Corvec, S. (2017) · Scientific Reports · doi:10.1038/srep42918 · Cited by 65
Arnold, M., Rajagukguk, Y. V., & Gramza‐Michałowska, A. (2021) · Foods · doi:10.3390/foods10030656 · Cited by 67
“Bone consists of 10% cells, 60% mineral crystals (crystalline hydroxyapatite), and 30% organic matrix [26].”
BackgroundLiu, C., Gao, X., Li, Y., Sun, W., Xu, Y., Tan, Y., Du, R., Zhong, G., Zhao, D., Liu, Z., et al. (2022) · Bone Research · doi:10.1038/s41413-022-00191-3 · Cited by 69
“This process involves osteoblast-governed bone formation and osteoclast-induced bone resorption.(2,3) Weightlessness-induced bone loss continues during long-term spaceflight.”
BackgroundMitochondria from osteolineage cells regulate myeloid cell-mediated bone resorption
Ding, P., Gao, C., Zhou, J., Mei, J., Li, G., Liu, D., Li, H., Liao, P., Meng, Y., Wang, B., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49159-3 · Cited by 72
“Considering that osteolineage and osteoclastic lineage cells are two main functional cell types that couple bone remodeling to maintain bone homeostasis 1 , we further investigated how these two lineages of cells interact with each other.”
Regulation of bone remodeling by vitamin K2
Myneni, V. D., & Mezey, É. (2016) · Oral Diseases · doi:10.1111/odi.12624 · Cited by 64
“Bone-lining cells separate the bone from the marrow (Robling et al, 2006; Feng and McDonald, 2011; Parra-Torres et al, 2013).”
BackgroundInfluentialXie, Z., Yu, H., Sun, X., Tang, P., Jie, Z., Chen, S., Wang, J., Qin, A., & Fan, S. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3334 · Cited by 64
“An imbalance between bone formation and bone resorption leads to pathogenesis and represents the etiology of many metabolic bone diseases, including osteopetrosis and osteoporosis.((3)) Osteoclasts are formed by the fusion of bone marrow monocytes/macrophages (BMMs), whereas osteoblasts are derived from mesenchymal st…”
BackgroundSteroid-associated osteonecrosis animal model in rats
Zheng, L., Wang, J., Kong, L., Huang, L., Tian, L., Pang, Q., Wang, X., & Qin, L. (2018) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2018.01.003 · Cited by 64
“LPS-induced inflammation could inhibit bone formation and increase bone resorption, which simulated the inflammation deceases [29,30].”
The Potential of FGF-2 in Craniofacial Bone Tissue Engineering: A Review
Novais, A., Chatzopoulou, E., Chaussain, C., & Gorin, C. (2021) · Cells · doi:10.3390/cells10040932 · Cited by 71
“Bone remodeling is essential for structural integrity, biomechanical stability, bone volume and calcium/phosphate homeostasis [1,4,25].”
BackgroundThe effect of P2X7 on cadmium-induced osteoporosis in mice
Ma, Y., Ran, D., Cao, Y., Zhao, H., Song, R., Zou, H., Gu, J., Yuan, Y., Bian, J., Zhu, J., et al. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.124251 · Cited by 64
Muruganandan, S., Govindarajan, R., McMullen, N. M., & Sinal, C. J. (2016) · Stem Cells · doi:10.1002/stem.2520 · Cited by 62
Role and Regulation of Transcription Factors in Osteoclastogenesis
Jiang, T., Xia, T., Qiao, F., Wang, N., Jiang, Y., & Xin, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216175 · Cited by 60
“Bone remodeling is an essential physiological process that can be affected by a number of variables, including menopause-related hormonal changes, age-related factors, changes in dietary intake, nutritional status, physical activity, medicines, and secondary illnesses [4,5].”
BackgroundAspera-Werz, R. H., Chen, T., Ehnert, S., Zhu, S., Fröhlich, T., & Nussler, A. K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122915 · Cited by 58
“Fractures in patients suffering from metabolic bone diseases are clearly associated with delayed or non-union fracture healing regarding imbalances between bone-forming and bone-resorbing cells [9,10].”
BackgroundBone-mineral density: clinical significance, methods of quantification and forensic applications
Kranioti, E. F., Bonicelli, A., & García-Donas, J. G. (2019) · Research and Reports in Forensic Medical Science · doi:10.2147/rrfms.s164933 · Cited by 61
“Fragility is the result of bone loss and degradation of bone structure.(25) Assessment of haversian canal and osteon area produced by an increase”
BackgroundGambacurta, A., Merlini, G., Ruggiero, C., Diedenhofen, G., Battista, N., Bari, M., Balsamo, M., Piccirillo, S., Valentini, G., Mascetti, G., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-44593-6 · Cited by 62
Xing, W., Liu, J., Cheng, S., Vogel, P., Mohan, S., & Brommage, R. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1935 · Cited by 59
“Osteoblasts synthesize and deposit bone matrix and increase bone mass while osteoclasts degrade mature and newly synthesized bone upon activation (1-3).”
BackgroundResolvin E1 regulates osteoclast fusion via DC‐STAMP and NFATc1
Zhu, M., Dyke, T. E. V., & Gyurko, R. (2013) · The FASEB Journal · doi:10.1096/fj.12-220228 · Cited by 62
“tion and decreased bone formation or vice versa (55).”
BackgroundOlives and Bone: A Green Osteoporosis Prevention Option
Chin, K., & Ima-Nirwana, S. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13080755 · Cited by 60
Huang, T., Li, Y., Ke, Y., Zhou, Y., Wang, Y., Jiang, Z., Wang, H., & Yang, G. (2018) · Biomaterials Science · doi:10.1039/c8bm01411f · Cited by 59
Faqeer, A., Wang, M., Alam, G., Padhiar, A. A., Zheng, D., Luo, Z., Zhao, I. S., Zhou, G., van den Beucken, J. J. J. P., Wang, H., et al. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122367 · Cited by 62
Rare earth-based materials for bone regeneration: Breakthroughs and advantages
Huang, Y., Zhai, X., Ma, T., Zhang, M., Pan, H., Lu, W. W., Zhao, X., Sun, T., Li, Y., Shen, J., et al. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.214236 · Cited by 60
The Potential Influence of Bone-Derived Modulators on the Progression of Alzheimer’s Disease
Yuan, J., Meloni, B. P., Shi, T., Bonser, A. M., Papadimitriou, J. M., Mastaglia, F. L., Zhang, C., Zheng, M., & Gao, J. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181249 · Cited by 58
“In addition, adult bone is the major source of minerals, including calcium, phosphorus, and magnesium, for the body [35, 36].”
Li, Q., Cheng, J. C. Y., Jiang, Q. Y., & Lee, W. (2021) · Aging Cell · doi:10.1111/acel.13301 · Cited by 60
“Finally, modulation of SIRT1 expression may prove effective for combatting Paget's disease, which is the second most common bone disorder after osteoporosis, both of which are associated with defects in bone remodeling (Feng & McDonald, 2011).”
BackgroundKim, J., Kim, M., Jung, H., & Sohn, Y. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4269 · Cited by 77
“The disruption of this balance leads to bone metabolic diseases, such as osteoporosis, arthritis, periodontitis and Paget's disease (1).”
BackgroundHigh Spatial Resolution MALDI Imaging Mass Spectrometry of Fresh-Frozen Bone
Good, C. J., Neumann, E. K., Butrico, C. E., Cassat, J. E., Caprioli, R. M., & Spraggins, J. M. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c04604 · Cited by 56
Osteoclasts and osteoarthritis: Novel intervention targets and therapeutic potentials during aging
Wang, H., Yuan, T., Wang, Y., Liu, C., Li, D., Li, Z., & Sun, S. (2024) · Aging Cell · doi:10.1111/acel.14092 · Cited by 64
“The continuing and balancing of this dynamic process is required for bone turnover and homeostasis maintenance (Feng & McDonald, 2011).”
BackgroundJensen, P. R., Andersen, T. L., Hauge, E., Bollerslev, J., & Delaissé, J. (2014) · Bone · doi:10.1016/j.bone.2014.12.004 · Cited by 57
“In both these diseases, osteoblast bone formation is insufficient compared to osteoclast resorption, thereby resulting in loss of bone mass and structure, and increased fracture risk [1].”
BackgroundLiu, W., Wang, P., Xie, Z., Wang, S., Ma, M., Li, J., Li, M., Cen, S., Tang, S., Guan, Z., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1448-x · Cited by 57
Huang, Y., Xiao, D., Huang, S., Zhuang, J., Zheng, X., Chang, Y., & Yin, D. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110365 · Cited by 57
Wan, Y., Lu, C. Y., Cao, J., Zhou, R., Yao, Y., Yu, J., Zhang, L., Zhao, H., Li, H., Zhao, J., et al. (2013) · Bone · doi:10.1016/j.bone.2012.12.052 · Cited by 55
“OPG, RANKL and M-CSF, secreted by osteoblasts and osteocytes, are major regulators for osteoclastogenesis [48].”
BackgroundAlvarenga, J. C., Fuller, H., Pasoto, S. G., & Pereira, R. M. R. (2016) · Osteoporosis International · doi:10.1007/s00198-016-3876-0 · Cited by 56
“Bone loss accelerates when menopause is reached [2].”
BackgroundAdamiak, M., Bujko, K., Cymer, M., Plonka, M., Glaser, T., Kucia, M., Ratajczak, J., Ulrich, H., Abdel‐Latif, A., & Ratajczak, M. Z. (2018) · Leukemia · doi:10.1038/s41375-018-0122-0 · Cited by 56
“The involvement of another cell type that lines trabecular bone, monocyte-derived osteoclasts [50], is still disputed at present.”
Li, M., Wan, P., Wang, W., Yang, K., Zhang, Y., & Han, Y. N. (2019) · Scientific Reports · doi:10.1038/s41598-018-37091-8 · Cited by 58
Green nanotechnology-based drug delivery systems for osteogenic disorders
Medina-Cruz, D., Mostafavi, E., Vernet-Crua, A., Chen, J., Shah, V., Cholula-Diaz, J. L., Guisbiers, G., Tao, J., García‐Martín, J. M., & Webster, T. J. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1727441 · Cited by 56
“5–10% of all fractures result in a delayed union or nonunion, with age, smoking, and diabetes as common comorbidities of poor healing [38,40].”
BackgroundA review article on factors affecting bone loss in dental implants
Nimbalkar, S., Dhatrak, P. N., Gherde, C., & Joshi, S. (2020) · Materials Today Proceedings · doi:10.1016/j.matpr.2020.07.428 · Cited by 56
The Involvement of Long Non-Coding RNAs in Bone
Aurilia, C., Donati, S., Palmini, G., Miglietta, F., Iantomasi, T., & Brandi, M. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083909 · Cited by 56
“On the other hand, an impaired equilibrium of the bone remodeling process may result in bone mass loss or excessive bone deposition, leading to the occurrence of pathological conditions affecting the bone [141,142].”
BackgroundNovel Bone Endocrine Networks Integrating Mineral and Energy Metabolism
Pi, M., & Quarles, L. D. (2013) · Current Osteoporosis Reports · doi:10.1007/s11914-013-0178-8 · Cited by 54
“The primary function of bone is to maintain its structural integrity through a self-renewal process, called bone remodeling [1].”
Mitochondrial dysfunction and therapeutic perspectives in osteoporosis
Liu, J., Gao, Z., & Liu, X. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1325317 · Cited by 59
“H202 attenuation contributes to osteoblast formation to promote bone growth through forkhead box O transcription factors (FoxOs) and estrogen regulation (59).”
BackgroundLysophosphatidic acid: A potential mediator of osteoblast–osteoclast signaling in bone
Sims, S. M., Panupinthu, N., Lapierre, D. M., Pereverzev, A., & Dixon, S. J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.08.001 · Cited by 56
Therapeutic ionizing radiation induced bone loss: a review of in vivo and in vitro findings
Zhang, J., Qiu, X., Xi, K., Hu, W., Pei, H., Nie, J., Wang, Z., Ding, J.-H., Shang, P., Li, B., et al. (2018) · Connective Tissue Research · doi:10.1080/03008207.2018.1439482 · Cited by 55
“resorption by osteoclasts is required to maintain bone quality (12).”
BackgroundInfluentialHan, S., & Kim, Y.-K. (2019) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x19500228 · Cited by 54
Zheng, Z., Cheng, H., Zhou, Y., Zhu, S.-T., Thu, P. M., Li, H., Li, P., & Xu, X. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-019-0484-5 · Cited by 57
“Interestingly, osteoporosis is mainly due to an excess of osteoclasts since the amount of bone resorbed by the osteoclasts is not restored with the new bone deposited by the osteoblasts, suggesting that cholesterol may directly act through osteoclasts to induce bone loss in postmenopausal women [40].”
BackgroundUbiquitin-Specific Protease 34 Inhibits Osteoclast Differentiation by Regulating NF-κB Signaling
Li, Q., Wang, M., Xue, H., Liu, W., Guo, Y., Xu, R., Shao, B., & Yuan, Q. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4015 · Cited by 55
“Disturbance of this coupling impairs skeletal integrity and increases individual susceptibility to diseases including osteoporosis, osteopetrosis, and Paget’s disease.((4,5)) Dysregulated osteoclastogenesis is a major cause of bone diseases and therefore an essential therapeutic target.”
BackgroundFunctional Diversity of Fibroblast Growth Factors in Bone Formation
Takei, Y., Minamizaki, T., & Yoshiko, Y. (2015) · International Journal of Endocrinology · doi:10.1155/2015/729352 · Cited by 54
“Representatives of the latter include parathyroid hormone (PTH), 1α,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ), and calcitonin [1].”
BackgroundA Review of Recent Developments in the Molecular Mechanisms of Bone Healing
Rodriguez-Merchan, E. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020767 · Cited by 57
Bone Cell Exosomes and Emerging Strategies in Bone Engineering
Vig, S., & Fernandes, M. H. (2022) · Biomedicines · doi:10.3390/biomedicines10040767 · Cited by 52
“The impairment of this bone remodeling process leads to development of bone disorders and diseases [36].”
BackgroundResearch progress of targeted therapy regulating Th17/Treg balance in bone immune diseases
Wang, X., Sun, B. T., Wang, Y., Gao, P., Song, J., Chang, W., Xiao, Z., Xi, Y., Li, Z., An, F., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1333993 · Cited by 56
“The physiological and pathological state of one system inevitably affects the other, based on an “ immune-bone remodelling ” regulatory network, which plays a complex and delicate role in bone remodelling (100, 112, 113).”
BackgroundChen, J., Lai, Y., Tsai, J.-J., & Hsiao, C. (2017) · Molecules · doi:10.3390/molecules22122068 · Cited by 52
“An imbalance in bone remodeling contributes to several pathologic conditions, including osteosclerosis, osteopetrosis, and osteoporosis [3].”
BackgroundPlastin 3 influences bone homeostasis through regulation of osteoclast activity
Neugebauer, J., Heilig, J., Hosseinibarkooie, S., Ross, B. C., Mendoza-Ferreira, N., Nolte, F., Peters, M., Hölker, I., Hupperich, K., Tschanz, T., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy318 · Cited by 54
Tissue Scaffolds As a Local Drug Delivery System for Bone Regeneration
Sarıgöl, E., & Hasçiçek, C. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0950-2_25 · Cited by 52
Role of Slit/Robo Signaling pathway in Bone Metabolism
Jiang, L., Sun, J., & Huang, D. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.66931 · Cited by 51
“Understanding the mechanism of bone coupling has important guiding significance for the treatment of metabolic bone diseases caused by bone resorption or steady-state destruction of bone formation, such as osteoporosis and ossification [4].”
BackgroundKong, Y., Zhang, Y., Cai, Y., Li, D., Yi, B., & Xu, Q. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110335 · Cited by 51
Xu, Y. Y., Song, D., Su, Y., Chen, J., Wu, L., Lian, H., Hai, N., Li, J., Jiang, J., Zhao, J., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114101 · Cited by 51
Bile acid metabolism regulatory network orchestrates bone homeostasis
Xiang, T., Deng, Z., Yang, C. H., Tan, J., Dou, C., Luo, F., & Chen, Y. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106943 · Cited by 54
3D printed osteochondral scaffolds: design strategies, present applications and future perspectives
Liu, G., Wei, X., Zhai, Y., Zhang, J., Li, J., Zhao, Z., Guan, T., & Zhao, D. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1339916 · Cited by 51
“MSCs can differentiate into bone cells and chondrocytes (Feng and McDonald, 2011).”
BackgroundSong, C. (2015) · Medical Science Monitor · doi:10.12659/msm.892247 · Cited by 51
“Bisphosphonates inhibit excessive bone resorption, but because bone resorption and bone formation are related, this inhibitory effect likely affects bone formation [47].”
Background
Metadata
- Authors
- Feng, X., & McDonald, J. M.
- Affiliations
- University of Alabama at Birmingham (US)
- ORCID
- Feng, Xu
- Venue
- Annual Review of Pathology: Mechanisms of Disease
- Publisher
- Annual Reviews
- Published
- 2011-02-28
- Volume
- 6
- Issue
- 1
- Pages
- 121-145
- ISSN
- 1553-4006 (ISSN-L)
- 1553-4014
- PMC
- PMC3571087
- OpenAlex
- W2166266977
- Cited by
- 1,272
- References
- 171
- Citations by year
- 2026: 59 · 2025: 109 · 2024: 102 · 2023: 124 · 2022: 135 · 2021: 142 · 2020: 107 · 2019: 117 · 2018: 86 · 2017: 68 · 2016: 59 · 2015: 47 · 2014: 36 · 2013: 37 · 2012: 29
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Annual Review of Pathology Mechanisms of Disease (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA109119)
- National Institute of Neurological Disorders and Stroke (R21NS061677, NS061677)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (5P30 AR0406031, R01AR047830, AR 47830, R01AR050235)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Keywords
- bone remodeling, bone resorption, bone formation, osteoclasts, osteoblasts, bone disease, menopause, hormonal changes, age-related bone loss, physical activity, drug-induced bone loss, mineral homeostasis, pathophysiology
- MeSH terms
- Animals, Bone Diseases, Humans, Bone Remodeling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
